Incidence and predictors of hemodynamic compromise due to high-grade AV block after TAVI

Background High-grade AV block (HAVB) is the most frequent adverse event after transcatheter aortic valve implantation (TAVI). In rare cases, HAVB is associated with hemodynamic compromise (HC) followed by syncope or application of cardiopulmonary resuscitation (CPR), but data on this severe complication are scarce. The aim of the present study was to investigate the incidence and predictors of HC due to HAVB in patients undergoing TAVI. Methods In this retrospective analysis of 4,602 TAVI cases between 2010 and 2022, 466 developed HAVB. Baseline characteristics and procedural and postprocedural findings were compared for patients with HC versus those without. Univariate and multivariable regression analyses were used to investigate independent predictors of HC. Results Forty-nine of 466 patients (10.5%) had HC due to HAVB after TAVI. Patients with HC had a longer hospital stay [10 (8–13) vs. 13 (9–18) days; p < 0.001], more frequent peripheral artery disease (PAD) (28.6% vs. 15.1%; p = 0.016), and lower hemoglobin levels [11.8 (±) vs. 12.5 (±) g/dl; p = 0.006]. In the HC group, HAVB onset post-TAVI was delayed compared with the non-HC group [2 (1–4) vs. 1 (0–3) days; p < 0.001]. Before HAVB onset, patients in the HC group more frequently developed post-TAVI delirium [18 (4.6%) vs. 11 (25.0%); p < 0.001]. In univariate regression analysis, PAD, hemoglobin, procedural time, contrast agent volume, and post-TAVI delirium were significant predictors of HC. After adjustment, only post-TAVI delirium and contrast agent volume remained independent predictors [OR 3.22 (95% CI: 1.05–9.89); p = 0.042 and OR: 1.01 (95% CI: 1.0–1.01); p = 0.04, respectively]. Conclusion HC due to HAVB after TAVI occurred in over 10% of cases. Development of post-TAVI delirium and contrast agent volume are independent predictors of this severe complication.

[1]  J. Webb,et al.  Transcatheter Aortic Valve Replacement with the Latest-Iteration Self-Expanding or Balloon-Expandable Valves: The Multicenter OPERA-TAVI Registry. , 2022, JACC. Cardiovascular interventions.

[2]  Tiantian Dong,et al.  Effect of regional anesthesia on the postoperative delirium: A systematic review and meta-analysis of randomized controlled trials , 2022, Frontiers in Surgery.

[3]  R. Puri,et al.  Feasibility and Safety of Same-Day Discharge Following Transfemoral Transcatheter Aortic Valve Replacement. , 2022, JACC. Cardiovascular interventions.

[4]  D. Wood,et al.  Same-Day Discharge Post–Transcatheter Aortic Valve Replacement During the COVID-19 Pandemic , 2022, JACC: Cardiovascular Interventions.

[5]  J. Carroll,et al.  Transcatheter Mitral Valve Therapy in the United States: A Report from the STS/ACC TVT Registry. , 2021, The Annals of thoracic surgery.

[6]  B. Prendergast,et al.  2021 ESC/EACTS Guidelines for the management of valvular heart disease. , 2021, European heart journal.

[7]  T. Nazif,et al.  Real-World Experience With the SAPIEN 3 Ultra Transcatheter Heart Valve , 2021, Circulation. Cardiovascular interventions.

[8]  J. Maessen,et al.  Occurrence and Persistency of Conduction Disturbances during Transcatheter Aortic Valve Implantation , 2021, Medicina.

[9]  J. Leipsic,et al.  Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research. , 2021, European heart journal.

[10]  Jeroen J. Bax,et al.  Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research. , 2021, Journal of the American College of Cardiology.

[11]  R. Guyton,et al.  Safety of same‐day discharge after uncomplicated, minimalist transcatheter aortic valve replacement in the COVID‐19 era , 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[12]  F. Mattace-Raso,et al.  Incidence, determinants and consequences of delirium in older patients after transcatheter aortic valve implantation , 2020, Age and ageing.

[13]  G. Tarantini,et al.  In-hospital and thirty-day outcomes of the SAPIEN 3 Ultra balloon-expandable transcatheter aortic valve: the S3U registry , 2020 .

[14]  T. Nazif,et al.  Three Generations of Self-Expanding Transcatheter Aortic Valves: A Report From the STS/ACC TVT Registry. , 2020, JACC. Cardiovascular interventions.

[15]  G. Tarantini,et al.  Sapien 3 Ultra balloon-expandable transcatheter aortic valve: in-hospital and 30-day results from the multicentre S3U registry. , 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[16]  J. Leipsic,et al.  Transcatheter Aortic‐Valve Replacement with a Balloon‐Expandable Valve in Low‐Risk Patients , 2019, The New England journal of medicine.

[17]  Andrew S. Mugglin,et al.  Transcatheter Aortic‐Valve Replacement with a Self‐Expanding Valve in Low‐Risk Patients , 2019, The New England journal of medicine.

[18]  T. Loetscher,et al.  Meta-analysis of Prevalence and Risk Factors for Delirium After Transcatheter Aortic Valve Implantation , 2018, The American journal of cardiology.

[19]  T. Walther,et al.  The ACURATE neo Transcatheter Heart Valve: A Comprehensive Analysis of Predictors of Procedural Outcome. , 2018, JACC. Cardiovascular interventions.

[20]  A. Colombo,et al.  Long-Term Outcomes in Patients With New Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement. , 2018, JACC. Cardiovascular interventions.

[21]  J. Oh,et al.  Early Outcomes With the Evolut PRO Repositionable Self-Expanding Transcatheter Aortic Valve With Pericardial Wrap. , 2018, JACC. Cardiovascular interventions.

[22]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[23]  C. Davidson,et al.  The impact of delirium on healthcare utilization and survival after transcatheter aortic valve replacement , 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[24]  B. Fridlund,et al.  Readmissions and mortality in delirious versus non-delirious octogenarian patients after aortic valve therapy: a prospective cohort study , 2016, BMJ Open.

[25]  A. Regueiro,et al.  Impact of New-Onset Left Bundle Branch Block and Periprocedural Permanent Pacemaker Implantation on Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis , 2016, Circulation. Cardiovascular interventions.

[26]  D. Wood,et al.  Vancouver Transcatheter Aortic Valve Replacement Clinical Pathway: Minimalist Approach, Standardized Care, and Discharge Criteria to Reduce Length of Stay , 2016, Circulation. Cardiovascular quality and outcomes.

[27]  M. Pasque,et al.  Delirium after surgical and transcatheter aortic valve replacement is associated with increased mortality. , 2016, The Journal of thoracic and cardiovascular surgery.

[28]  E. Schwammenthal,et al.  Inverse Relationship Between Membranous Septal Length and the Risk of Atrioventricular Block in Patients Undergoing Transcatheter Aortic Valve Implantation. , 2015, JACC. Cardiovascular interventions.

[29]  A. Cribier,et al.  Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation with the Edwards SAPIEN-XT prosthesis. , 2015, The American journal of cardiology.

[30]  H. Herrmann,et al.  Rationale, development, implementation, and initial results of a fast track protocol for transfemoral transcatheter aortic valve replacement (TAVR) , 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[31]  T. Walther,et al.  Challenges of coronary angiography and intervention in patients previously treated by TAVI , 2015, Clinical Research in Cardiology.

[32]  Peter Jüni,et al.  Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. , 2014, Journal of the American College of Cardiology.

[33]  I. Norkiene,et al.  Incidence and Risk Factors of Early Delirium after Cardiac Surgery , 2013, BioMed research international.

[34]  Lluís Mont,et al.  2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[35]  Lluís Mont,et al.  2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). , 2013, European heart journal.

[36]  Jennifer Taylor,et al.  ESC/EACTS Guidelines on the management of valvular heart disease. , 2012, European heart journal.

[37]  F. Schmidt Meta-Analysis , 2008 .

[38]  A. Kadish,et al.  Left ventricular function during and after right ventricular pacing. , 2004, Journal of the American College of Cardiology.

[39]  John Gorcsan,et al.  Echocardiography and Resynchronization A Mechanism for Immediate Reduction in Mitral Regurgitation After Cardiac Resynchronization Therapy Insights From Mechanical Activation Strain Mapping , 2004 .

[40]  Assaf Bash,et al.  Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis: First Human Case Description , 2002, Circulation.

[41]  F W Prinzen,et al.  Redistribution of myocardial fiber strain and blood flow by asynchronous activation. , 1990, The American journal of physiology.

[42]  OUP accepted manuscript , 2022, Europace.

[43]  T. Nazif A Propensity-Matched Analysis From the United States , 2021 .

[44]  T. Walther,et al.  Pacemaker implantation after TAVI: predictors of AV block persistence , 2017, Clinical Research in Cardiology.

[45]  M. Mack,et al.  Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry. , 2015, JACC. Cardiovascular interventions.

[46]  J. Nielsen,et al.  ESC Guidelines on cardiac pacing and cardiac resynchronization therapy , 2014 .

[47]  I. Harris,et al.  A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2010 .

[48]  V. Preedy,et al.  Prospective Cohort Study , 2010 .